- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 3O6: 1-(4-fluorophenyl)-3-[4-(4-fluorophenyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea(Non-covalent)
- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 5 residues within 4Å:- Chain A: H.8, Y.345, H.349, L.352, R.353
Ligand excluded by PLIPEDO.3: 6 residues within 4Å:- Chain A: A.50, L.291, S.296, K.297, Y.298, I.355
Ligand excluded by PLIPEDO.4: 4 residues within 4Å:- Chain A: L.69, N.70, K.141, K.182
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: I.207, I.476, P.477, L.478, Q.480, R.498
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: F.185, I.207, F.219
- Ligands: EDO.7
Ligand excluded by PLIPEDO.7: 4 residues within 4Å:- Chain A: E.177, V.181, F.219
- Ligands: EDO.6
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: K.18, E.229, T.282, H.283, G.284, K.411
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain B: D.285, K.287, D.377, N.378, N.379
- Ligands: EDO.18
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain B: A.50, S.296, K.297, Y.298, I.355
Ligand excluded by PLIPEDO.15: 7 residues within 4Å:- Chain B: F.22, S.23, Y.26, N.230, M.281, Y.506
- Ligands: 3O6.12
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain B: E.177, N.218, Y.241, G.243, T.244, N.245, H.265
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain B: K.18, E.229, T.282, H.283, G.284, D.285, K.411
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain B: D.285, D.286
- Ligands: EDO.13
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain B: P.477, L.478, Q.480, R.498
Ligand excluded by PLIPEDO.22: 5 residues within 4Å:- Chain C: H.8, Y.345, H.349, L.352, R.353
Ligand excluded by PLIPEDO.23: 6 residues within 4Å:- Chain C: A.50, L.291, S.296, K.297, Y.298, I.355
Ligand excluded by PLIPEDO.24: 4 residues within 4Å:- Chain C: L.69, N.70, K.141, K.182
Ligand excluded by PLIPEDO.25: 6 residues within 4Å:- Chain C: I.207, I.476, P.477, L.478, Q.480, R.498
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain C: F.185, I.207, F.219
- Ligands: EDO.27
Ligand excluded by PLIPEDO.27: 4 residues within 4Å:- Chain C: E.177, V.181, F.219
- Ligands: EDO.26
Ligand excluded by PLIPEDO.28: 6 residues within 4Å:- Chain C: K.18, E.229, T.282, H.283, G.284, K.411
Ligand excluded by PLIPEDO.33: 6 residues within 4Å:- Chain D: D.285, K.287, D.377, N.378, N.379
- Ligands: EDO.38
Ligand excluded by PLIPEDO.34: 5 residues within 4Å:- Chain D: A.50, S.296, K.297, Y.298, I.355
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain D: F.22, S.23, Y.26, N.230, M.281, Y.506
- Ligands: 3O6.32
Ligand excluded by PLIPEDO.36: 7 residues within 4Å:- Chain D: E.177, N.218, Y.241, G.243, T.244, N.245, H.265
Ligand excluded by PLIPEDO.37: 7 residues within 4Å:- Chain D: K.18, E.229, T.282, H.283, G.284, D.285, K.411
Ligand excluded by PLIPEDO.38: 3 residues within 4Å:- Chain D: D.285, D.286
- Ligands: EDO.33
Ligand excluded by PLIPEDO.39: 4 residues within 4Å:- Chain D: P.477, L.478, Q.480, R.498
Ligand excluded by PLIP- 2 x MG: MAGNESIUM ION(Non-covalent)
- 4 x IMD: IMIDAZOLE(Non-covalent)
IMD.10: 8 residues within 4Å:- Chain A: K.208, E.212, K.213, F.214, T.220, Q.235, T.238, H.240
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.235
- pi-Stacking: A:H.240
IMD.20: 7 residues within 4Å:- Chain B: Y.39, D.40, E.152
- Chain D: Y.39, D.40, E.152
- Ligands: IMD.40
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.40, B:D.40
IMD.30: 8 residues within 4Å:- Chain C: K.208, E.212, K.213, F.214, T.220, Q.235, T.238, H.240
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:Q.235
- pi-Stacking: C:H.240
IMD.40: 7 residues within 4Å:- Chain B: Y.39, D.40, E.152
- Chain D: Y.39, D.40, E.152
- Ligands: IMD.20
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain B- Hydrogen bonds: D:D.40, B:D.40
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakazawa Hewitt, S. et al., Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase. Acs Infect Dis. (2016)
- Release Date
- 2016-05-04
- Peptides
- Proline--tRNA ligase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 3O6: 1-(4-fluorophenyl)-3-[4-(4-fluorophenyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]urea(Non-covalent)
- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 4 x IMD: IMIDAZOLE(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakazawa Hewitt, S. et al., Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase. Acs Infect Dis. (2016)
- Release Date
- 2016-05-04
- Peptides
- Proline--tRNA ligase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B